These findings collectively suggest that PRDM1 acts as a crucial transcription factor for SLC30A9 in cervical cancer, with its enhanced binding to the promoter region likely driving the aberrant overexpression of SLC30A9 and potentially contributing to the pathogenesis of this malignancy. The gene discussed is PRDM1; the disease is cervical cancer.